Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Chubb
Covington
Julphar
US Department of Justice
Healthtrust
Federal Trade Commission
Fuji
Harvard Business School

Generated: January 16, 2018

DrugPatentWatch Database Preview

IBANDRONATE SODIUM Drug Profile

« Back to Dashboard

When do Ibandronate Sodium patents expire, and what generic alternatives are available?

Ibandronate Sodium is a drug marketed by Accord Hlthcare, Apotex Inc, Aurobindo Pharma Ltd, Emcure Pharms Ltd, Mylan Labs Ltd, Sagent Pharms, Sun Pharm Inds Ltd, Dr Reddys Labs Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Orchid Hlthcare, Sun Pharm Industries, and Watson Labs Teva. and is included in fifteen NDAs.

The generic ingredient in IBANDRONATE SODIUM is ibandronate sodium. There are sixteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the ibandronate sodium profile page.
Drug patent expirations by year for IBANDRONATE SODIUM
Pharmacology for IBANDRONATE SODIUM
Ingredient-typeDiphosphonates
Drug ClassBisphosphonate

US Patents and Regulatory Information for IBANDRONATE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare IBANDRONATE SODIUM ibandronate sodium INJECTABLE;INTRAVENOUS 206058-001 Feb 5, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Ltd IBANDRONATE SODIUM ibandronate sodium INJECTABLE;INTRAVENOUS 090853-001 Feb 14, 2014 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Emcure Pharms Ltd IBANDRONATE SODIUM ibandronate sodium INJECTABLE;INTRAVENOUS 203987-001 Sep 2, 2014 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc IBANDRONATE SODIUM ibandronate sodium TABLET;ORAL 078995-001 Mar 19, 2012 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc IBANDRONATE SODIUM ibandronate sodium TABLET;ORAL 078948-001 Mar 19, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries IBANDRONATE SODIUM ibandronate sodium TABLET;ORAL 078996-001 Aug 15, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc IBANDRONATE SODIUM ibandronate sodium INJECTABLE;INTRAVENOUS 204222-001 Oct 16, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd IBANDRONATE SODIUM ibandronate sodium INJECTABLE;INTRAVENOUS 205332-001 Aug 19, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sagent Pharms IBANDRONATE SODIUM ibandronate sodium INJECTABLE;INTRAVENOUS 202235-001 Sep 2, 2014 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd IBANDRONATE SODIUM ibandronate sodium INJECTABLE;INTRAVENOUS 202671-001 Sep 2, 2014 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Citi
Johnson and Johnson
Queensland Health
Covington
QuintilesIMS
Colorcon
Accenture
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot